Skip to Content
주식/증권 📈 긍정적

2 Reasons to Avoid BMRN and 1 Stock to Buy Instead

Yahoo Finance 07/17/2026 03:45:46 PM 10회
요약

BioMarin Pharmaceutical trades at $59.99 per share and has stayed right on track with the overall market, gaining 6.5% over the last six months. At the same time, the S&P 500 has returned 11.4%.

원문 기사 보기
관련 뉴스
CVD Equipment outlines debt-free focus after SDC sale, ends Q2 with $23.5M cash and evaluates order risk tied to customer Chapter 11
08/12/2026
S&P 500 ends higher as CoreWeave results fuel AI optimism
08/12/2026
CuriosityStream expects $77M-$82M 2026 revenue while expanding AI training licensing offerings
08/12/2026
The Market Is Paying You To Own MELI. Why?
08/12/2026
뉴스 목록으로